Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Testing a Smartphone App to Support a Mediterranean Diet and Strength Exercise (App-etite)

5 novembre 2026 mis à jour par: Liverpool John Moores University

App-etite for Change: A Four-Week Feasibility Randomised Controlled Trial of a Smartphone Application to Support Adherence to a Mediterranean-Style Diet and Resistance Exercise

Eating a Mediterranean-style diet and doing regular resistance training are both known to lower the risk of heart disease. However, most people find it hard to stick to these habits over time, and few smartphone apps support both diet and strength training together. This study tests a smartphone app called MedEx Tracker, which was developed by the research team. The app lets people record what they have eaten against a set of Mediterranean diet targets, record the weight and repetitions for each set of their resistance training, and see how they are doing through a progress screen. It also sends reminders during the day and suggests when to increase training weight. Healthy adults aged 18 to 55 will be randomly assigned to one of two groups. Both groups will be given the same Mediterranean diet targets and the same strength training programme. One group will receive this through the app; the other will receive it as a printed booklet. This means any difference between the groups should be due to the app itself rather than to different advice. Everyone will attend the laboratory before and after the four weeks for measurements and questionnaires. The main aim is to find out whether the app is usable and acceptable to participants, and whether it helps people stick to a Mediterranean-style diet and a resistance training programme. The findings will be used to decide whether the app is suitable for a larger future study.

Aperçu de l'étude

Description détaillée

This is a four-week, two-arm, parallel-group feasibility randomised controlled trial conducted at Liverpool John Moores University. Healthy adults aged 18 to 55 years who own a smartphone will be randomised in a 1:1 ratio to an application-supported intervention arm (APP) or a control arm (CON). Allocation will be generated by a staff member independent of the project using a computerised random number generator. Blinding of participants is not feasible given the nature of the intervention; statistical analysis will be performed by a blinded statistician.

All participants, irrespective of allocation, will receive the same printed booklet containing Mediterranean-style dietary serving targets with serving size definitions and a structured resistance exercise programme with written technique guidance and load progression criteria, and will be asked to follow these to the best of their ability throughout the four-week intervention period. Participants in the APP arm will additionally receive access to MedEx Tracker, a purpose-built cross-platform mobile application. The application supports structured daily and weekly dietary logging against the prescribed serving targets, set-level recording of resistance exercise including load and repetitions, automated load progression prompts, an inter-set rest timer, embedded exercise demonstration videos, a library of Mediterranean recipes, and a progress dashboard displaying computed daily and weekly dietary compliance. Automated reminders are delivered three times daily for diet and every alternate day for exercise. Both arms therefore receive an identical prescription, with access to the application, and the self-monitoring, progress feedback and automated reminders it provides, representing the only difference between groups.

All participants will attend the laboratory before and after the intervention period. Primary outcomes are adherence to a Mediterranean-style diet and a resistance exercise programme, and the usability, acceptability and engagement with the application. Dietary adherence will be assessed using the 14-item Mediterranean Diet Adherence Screener and resistance exercise adherence as weekly muscle-strengthening frequency using the long form of the Muscle-Strengthening Exercise Questionnaire. Usability and acceptability will be assessed using the Mobile App Usability Questionnaire and the user version of the Mobile Application Rating Scale, supplemented by a focus group at follow-up. Engagement will be derived from application-generated data, including frequency of access and completeness of dietary and resistance exercise records. Secondary outcomes include recruitment and retention rates, dietary intake derived from three-day food records, body mass and body composition.

The study is not powered to detect definitive between-group differences. Its purpose is to establish whether the application functions as an adherence support and tracking tool of sufficient quality to be used within a subsequent fully powered trial examining LDL aggregation susceptibility.

Type d'étude

Interventionnel

Inscription (Estimé)

30

Phase

  • N'est pas applicable

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Coordonnées de l'étude

  • Nom: Alexandros M Amorginos, MSc
  • Numéro de téléphone: +447713180851
  • E-mail: spsaamor@ljmu.ac.uk

Lieux d'étude

    • Merseyside
      • Liverpool, Merseyside, Royaume-Uni, L3 3AF
        • Liverpool John Moores University
        • Contact:

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

18 ans à 55 ans (Adulte)

Accepte les volontaires sains

Oui

Sexes éligibles pour l'étude

Tout

La description

Inclusion Criteria:

  • own and use a smartphone
  • no contraindication to exercise on a pre-activity readiness questionnaire (PARQ)

Exclusion Criteria:

  • pregnant or nursing
  • presence of a dietary allergy or food intolerance
  • adherence to a restrictive diet (keto, carnivore, vegan, vegetarian etc)

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: La prévention
  • Répartition: Randomisé
  • Modèle interventionnel: Affectation parallèle
  • Masquage: Aucun (étiquette ouverte)

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Expérimental: Application-supported

Participants receive Mediterranean-style dietary serving targets and a structured resistance exercise programme as a printed booklet, together with access to the MedEx Tracker mobile application, which provides self-monitoring, progress feedback, automated reminders and load progression prompts over four weeks.

MedEx Tracker is a purpose-built cross-platform smartphone application developed by the research team to support adherence to a Mediterranean-style diet and a resistance training programme. Participants record daily servings of six food groups and weekly servings of five further food groups against defined targets, with serving definitions available within the application. Resistance training is recorded at the level of individual sets, capturing the load lifted and repetitions completed, with demonstration videos, automated prompts to increase or reduce load based on previous performance, and an inter-set rest timer. A progress dashboard displays a computed daily and weekly dietary compliance percentage, sessions completed, and seven-day activity calendars. The application also provides a library of Mediterranean diet-aligned recipes and delivers automated reminders three times daily for diet and every alternate day for exercise.

A printed booklet containing Mediterranean-style dietary serving targets with accompanying serving size definitions, and the prescribed resistance exercises with written technique guidance and load progression criteria. Participants are asked to follow the programme to the best of their ability over the four-week study period.

Comparateur actif: Printed booklet

Participants receive the same printed booklet containing Mediterranean-style dietary serving targets and a structured resistance exercise programme over four weeks. No application access, progress feedback or automated reminders are provided.

A printed booklet containing Mediterranean-style dietary serving targets with accompanying serving size definitions, and the prescribed resistance exercises with written technique guidance and load progression criteria. Participants are asked to follow the programme to the best of their ability over the four-week study period.

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Mediterranean diet adherence
Délai: Baseline and week 4

Adherence measured using the 14-item Mediterranean Diet Adherence Screener (MEDAS). Total score ranges from 0 to 14, with higher scores indicating greater adherence

Baseline and week 4
Resistance exercise adherence
Délai: Baseline and week 4

Weekly muscle-strengthening exercise frequency, self-reported using the long form of the Muscle-Strengthening Exercise Questionnaire (MSEQ). Reported in days per week (minimum 0, maximum 7); higher values indicate more frequent muscle-strengthening exercise, i.e. greater adherence. This is a frequency count rather than a scale score; the MSEQ has no composite total score. Total weekly frequency is taken as the highest frequency reported across the four MSEQ exercise types.

Baseline and week 4
Application usability
Délai: Week 4 (end of intervention)

Usability assessed in the intervention group using the Mobile App Usability Questionnaire (MAUQ). Higher scores indicate better usability.

Week 4 (end of intervention)
Application quality and acceptability
Délai: Week 4 (end of intervention)

Assessed in the intervention group using the user version of the Mobile Application Rating Scale (uMARS), scored across engagement, functionality, aesthetics and information quality. Scoring is 1-5 (higher= better).

Week 4 (end of intervention)
Engagement with the application
Délai: Weeks 1-4, recorded continuously by the application

Frequency of application access and completeness of dietary and resistance training records, derived from application-generated data in the intervention group.

Weeks 1-4, recorded continuously by the application

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
Dietary intake
Délai: Baseline and week 4

Energy and macronutrient intake derived from three-day food records.

Baseline and week 4
Body mass
Délai: Baseline and week 4

In kg using calibrated scales

Baseline and week 4
Body composition
Délai: Baseline and week 4

Fat mass and fat-free mass assessed by bioelectrical impedance analysis

Baseline and week 4
Recruitment rate
Délai: From the start of recruitment to randomisation of the final participant (up to approximately 4 months)

Number of participants randomised per month of recruitment. Also reported:

  • number screened
  • proportion of those screened who are eligible
  • proportion of eligible people who consent and are randomised
From the start of recruitment to randomisation of the final participant (up to approximately 4 months)
Retention rate
Délai: Baseline to week 4 (end of intervention)

Proportion of randomised participants who attend the week-4 follow-up visit, reported overall and by arm, with reasons for withdrawal where given.

Baseline to week 4 (end of intervention)

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Les enquêteurs

  • Directeur d'études: Richard P Kirwan, PhD, Liverpool John Moores University

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Estimé)

1 novembre 2026

Achèvement primaire (Estimé)

1 février 2027

Achèvement de l'étude (Estimé)

1 mars 2027

Dates d'inscription aux études

Première soumission

9 octobre 2026

Première soumission répondant aux critères de contrôle qualité

13 octobre 2026

Première publication (Réel)

21 octobre 2026

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

6 novembre 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

5 novembre 2026

Dernière vérification

1 octobre 2026

Plus d'information

Termes liés à cette étude

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

NON

Description du régime IPD

Individual participant data will not be made publicly available. The small sample size and single-site recruitment mean that participants could potentially be identified from combinations of demographic and anthropometric variables. Requests for data access will be considered on an individual basis by the corresponding author, subject to approval by the Liverpool John Moores University Research Ethics Committee and completion of a data sharing agreement.

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner